Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | ADH4 | P08319 | 1/20 | 0.42 |
| ▸ | ADH7 | P40394 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3675293 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL13279660 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL4663784 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL10782729 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL1900761 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL19511992 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL9014021 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL17336107 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL4037962 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A | |
| SCHEMBL3433268 | 1.00 | TSHR (0.42) | TSHROPRM1ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144208-A1 | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE BIS-UREA DERIVATIVE | L' OREAL S.A. (FR) | 2011-06-16 | — | — | US | claimed |
| US-20080267896-A1 | Continuous liquid fatty phase; non-silicone oils; for application to skin, hair | L'OREAL S.A. (FR) | 2008-10-30 | — | — | US | claimed |
| US-11345846-B2 | Alkylphenol copolymer | SI GROUP, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| WO-2021127622-A1 | LUBRICANT COMPOSITION COMPRISING AN ANTIOXIDANT COMPOSITION | SI GROUP, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021126644-A1 | ACRYLATE COPOLYMER AND USE THEREOF | SI GROUP, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| US-20210189035-A1 | Acrylate Copolymer and Use Thereof | SI GROUP, INC. | 2021-06-24 | — | — | US | disclosed |
| US-20210189280-A1 | Lubricant Composition Comprising an Antioxidant Composition | SI GROUP, INC. | 2021-06-24 | — | — | US | disclosed |
| US-20210061944-A1 | Modified Phenol Polymer and Use Thereof | SI GROUP, INC. | 2021-03-04 | — | — | US | disclosed |
| US-20210002539-A1 | Alkylphenol Copolymer | SI GROUP, INC. | 2021-01-07 | — | — | US | disclosed |
| CN-110272553-A | Adaptability vapor barrier | 罗地亚经营管理公司 | 2019-09-24 | — | — | CN | disclosed |
| CN-105392630-A | Adaptive Vapor Barrier | RHODIA OPERATIONS | 2016-03-09 | — | — | CN | disclosed |
| US-20110144208-A1 | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE BIS-UREA DERIVATIVE | L' OREAL S.A. (FR) | 2011-06-16 | — | — | US | disclosed |
| US-20080267896-A1 | Continuous liquid fatty phase; non-silicone oils; for application to skin, hair | L'OREAL S.A. (FR) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080267896-A1 | Continuous liquid fatty phase; non-silicone oils; for application to skin, hair | KRT18, CUTA, DEGS1 | TSHR 3962/4885OPRM1 4144/4885ADH1B 1933/4885 |
| US-20110144208-A1 | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE BIS-UREA DERIVATIVE | KRT18, DEGS1, CUTA | TSHR 4379/4885OPRM1 3005/4885ADH1B 838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.